IKT — Inhibikase Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Inhibikase Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	14	40.8	23.1	13.3	97.5
Net Total Accounts Receivable
Net Total Receivables	—	0.11	0.04	0	—
Prepaid Expenses
Total Current Assets	14.8	42.5	24.4	14.2	98.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	—	0.565	0.296	0.149
Other Long Term Assets
Total Assets	14.8	42.5	24.9	14.5	98.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.72	4.05	3.7	3.44	3.73
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	5	4.05	3.9	3.53	3.73
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	9.78	38.4	21	11	94.9
Total Liabilities & Shareholders' Equity	14.8	42.5	24.9	14.5	98.6
Total Common Shares Outstanding